Content about Pharmacist Society

December 3, 2013

The Centers for Disease Control and Prevention has published a set of recommendations on collaborative practice agreements between pharmacists and physicians in an effort to improve healthcare quality, under a partnership with the American Pharmacists Association's philanthropic wing.

WASHINGTON — The Centers for Disease Control and Prevention has published a set of recommendations on collaborative practice agreements between pharmacists and physicians in an effort to improve healthcare quality, under a partnership with the American Pharmacists Association's philanthropic wing.

December 3, 2013

Elderly and disabled people nationwide have saved almost $9 billion on prescription drugs thanks to the Patient Protection and Affordable Care Act, according to a new study by the Centers for Medicare and Medicaid Services.

WASHINGTON — Elderly and disabled people nationwide have saved almost $9 billion on prescription drugs thanks to the Patient Protection and Affordable Care Act, according to a new study by the Centers for Medicare and Medicaid Services.

December 3, 2013

The Food and Drug Administration has given tentative approval to a generic drug for treating community-acquired pneumonia, agency records showed.

SILVER SPRING, Md. — The Food and Drug Administration has given tentative approval to a generic drug for treating community-acquired pneumonia, agency records showed.

According to the FDA's website, the agency granted the preliminary authorization for Roxane Labs' linezolid oral suspension in the 100-mg-per-5-mL strength.

December 3, 2013

Forest Labs is spending at least $240 million to buy rights to a psychiatric drug made by Merck, the New York-based drug maker said.

NEW YORK — Forest Labs is spending at least $240 million to buy rights to a psychiatric drug made by Merck, the New York-based drug maker said.

Forest said it would buy the U.S. rights for Merck's Saphris (asenapine), a tablet dissolved under the tongue for the treatment of schizophrenia and manic episodes in patients with bipolar disorder. Forest will pay Merck $240 million upfront, as well as milestone payments based on sales, while Merck will supply the drug. Forest will market the drug and conduct clinical studies.

December 3, 2013

Takeda Pharmaceutical Co., the largest drug maker in Japan, has hired the head of GlaxoSmithKline's vaccines division as its COO, Takeda said.

OSAKA, Japan — Takeda Pharmaceutical Co., the largest drug maker in Japan, has hired the head of GlaxoSmithKline's vaccines division as its COO, Takeda said.

Christophe Weber was elected at the drug maker's board of directors meeting to become COO and candidate as the next CEO. Current president and CEO Yasuchika Hasegawa is expected to be named chairman and CEO.

Weber is currently president and general manager of GSK Vaccines, CEO of GSK Biologicals in Belgium and a member of GSK's global corporate executive team.

December 3, 2013

Impax Labs has settled a patent-infringement suit filed by Purdue Pharma concerning the opioid painkiller OxyContin, Impax said Tuesday.

HAYWARD, Calif. — Impax Labs has settled a patent-infringement suit filed by Purdue Pharma concerning the opioid painkiller OxyContin, Impax said Tuesday.

December 3, 2013

Officials in Rhode Island may set up a registry that would allow doctors and pharmacists to track patients who have problems with drug abuse, according to published reports.

NEW YORK — Officials in Rhode Island may set up a registry that would allow doctors and pharmacists to track patients who have problems with drug abuse, according to published reports.

The Associated Press reported that the proposed registry would track prescriptions for drugs that are controlled substance and allow healthcare professionals to track their usage, similar to a monitoring program set up in New York this year. A task force that includes state lawmakers, health officials and healthcare professionals met Monday to look at the idea.

December 3, 2013

Rite Aid is offering a $5 discount on flu shots as a way to encourage more people to protect themselves, the retail pharmacy chain said.

CAMP HILL, Pa. — Rite Aid is offering a $5 discount on flu shots as a way to encourage more people to protect themselves, the retail pharmacy chain said.

Rite Aid said that in recognition of National Influenza Vaccination Week, which runs between Dec. 8 and Dec. 14, it would offer flu shots at its stores for $24.99. NIVW started in 2005 as a national campaign by the Centers for Disease Control and Prevention, which recommends annual flu shots for everyone aged 6 months and older.

December 3, 2013

The Food and Drug Administration has given tentative approval to a generic drug used to treat prostate disease, agency records showed.

SILVER SPRING, Md. — The Food and Drug Administration has given tentative approval to a generic drug used to treat prostate disease, agency records showed.

The FDA granted tentative approval to Roxane Labs' dutasteride capsules in the 0.5-mg strength. The drug is a generic version of GSK's Avodart, used to treat benign prostatic hyperplasia.

Tentative approval means that a drug meets the agency's conditions for approval, but can't receive final approval until Avodart loses its patent protection, which will occur in 2015.

 

December 2, 2013

Bartell Drugs will open retail clinics at three of its stores under a partnership with a local health organization, the Seattle-based regional drug store chain said Monday.

SEATTLE — Bartell Drugs will open retail clinics at three of its stores under a partnership with a local health organization, the Seattle-based regional drug store chain said Monday.

Bartell said it would partner with Group Health Cooperative to open clinics at two stores in Seattle and one in the neighboring city of Bellevue, Wash., staffed by nurse practitioners from Group Health. The program is called CareClinic: Group Health at Bartell Drugs, or CareClinic for short, and the initial three clinics will open between January and March 2014.

December 2, 2013

Shionogi and Egalet have entered a deal worth up to $425 million for the development of abuse-deterrent opioid painkillers, Egalet said.

MALVERN, Pa. — Shionogi and Egalet have entered a deal worth up to $425 million for the development of abuse-deterrent opioid painkillers, Egalet said.

The deal centers on the development and potential commercialization of experimental drugs containing the opioid painkiller hydrocodone.

December 2, 2013

The Food and Drug Administration has approved a generic version of a drug for schizophrenia and bipolar disorder made by Jubilant Life Sciences, the Indian drug maker said.

NOIDA, India — The Food and Drug Administration has approved a generic version of a drug for schizophrenia and bipolar disorder made by Jubilant Life Sciences, the Indian drug maker said.

Jubilant announced the approval of quetiapine fumarate tablets in the 25-mg strength. The drug is a generic version of AstraZeneca's Seroquel.

Various versions of the drug have annual sales of about $59 million, according to IMS Health.

 

December 2, 2013

The Food and Drug Administration has designated a drug made by Teva Pharmaceutical Industries as an orphan drug, the company said.

JERUSALEM — The Food and Drug Administration has designated a drug made by Teva Pharmaceutical Industries as an orphan drug, the company said.

Teva said the drug, Treanda (bendamustine hydrochloride), received the designation for indolent B-cell non-Hodgkins lymphoma through October 2015 that has progressed during or within six months of treatment with a regimen containing Rituxan (rituximab), marketed by Genentech and Biogen Idec. The FDA gives orphan drug designation to treatments for diseases affecting fewer than 200,000 people in the United States.

December 2, 2013

Drug maker Mylan and the Elton John AIDS Foundation will donate $1 million to the Business Leadership Council for a Generation Born HIV Free, the two said.

PITTSBURGH — Drug maker Mylan and the Elton John AIDS Foundation will donate $1 million to the Business Leadership Council for a Generation Born HIV Free, the two said.

December 2, 2013

Rite Aid has promoted Karen Staniforth, VP pharmacy for the chain's mid-Atlantic division, to group VP pharmacy initiatives and clinical services, the company said Monday.

CAMP HILL, Pa. – Rite Aid has promoted Karen Staniforth, VP pharmacy for the chain's mid-Atlantic division, to group VP pharmacy initiatives and clinical services, the company said Monday.

December 2, 2013

Sandoz will market an authorized generic version of an attention deficit hyperactivity disorder drug made by Shire under a contract between the two companies, Shire said Monday.

PHILADELPHIA — Sandoz will market an authorized generic version of an attention deficit hyperactivity disorder drug made by Shire under a contract between the two companies, Shire said Monday.

Shire said Sandoz, the generics division of Swiss drug maker Novartis, would market an authorized generic version of Adderall XR (amphetamine; dextroamphetamine).

December 2, 2013

Vaccines have prevented an estimated 100 million cases of serious childhood contagious diseases in the nearly 90 years since the vaccine for pertussis, or whooping cough, became available, according to a new study.

PITTSBURGH — Vaccines have prevented an estimated 100 million cases of serious childhood contagious diseases in the nearly 90 years since the vaccine for pertussis, or whooping cough, became available, according to a new study.

December 2, 2013

Patients who received appointment-based medication synchronization were up to six times more likely to adhere to their therapies than those who didn't, according to a study of patients at rural Thrifty White Pharmacy locations in the Midwest published in the Journal of the American Pharmacists Association.

WASHINGTON — Patients who received appointment-based medication synchronization were up to six times more likely to adhere to their therapies than those who didn't, according to a study of patients at rural Thrifty White Pharmacy locations in the Midwest published in the Journal of the American Pharmacists Association.

November 26, 2013

Drug maker AbbVie is launching an international awareness campaign focused on women living with HIV, the drug maker said Tuesday.

NORTH CHICAGO, Ill. – Drug maker AbbVie is launching an international awareness campaign focused on women living with HIV, the drug maker said Tuesday.

November 26, 2013

German chemical and pharmaceutical giant Bayer plans to buy Norwegian drug maker Algeta for $2.4 billion, Algeta confirmed Tuesday.

OSLO, Norway — German chemical and pharmaceutical giant Bayer plans to buy Norwegian drug maker Algeta for $2.4 billion, Algeta confirmed Tuesday.

Responding to earlier media reports, the Norway-based maker of cancer drugs said Bayer would acquire it for 336 krone per share, equal to about $55.05. The company's share price increased to 349.40 krone, or $57.21 per share, in late-afternoon trading Tuesday on the Oslo Stock Exchange.

November 26, 2013

The Food and Drug Administration has accepted Purdue Pharma's regulatory approval application for a new opioid drug, Purdue said Tuesday.

STAMFORD, Conn. — The Food and Drug Administration has accepted Purdue Pharma's regulatory approval application for a new opioid drug, Purdue said Tuesday.

The drug maker announced the FDA's acceptance of its application for Targiniq (oxycodone hydrochloride; naloxone hydrochloride) controlled-release tablets. The drug combines oxycodone with the opioid agonist nalxone.

November 26, 2013

Generic drug maker Hospira will have its investor conference next week, the company said Tuesday.

LAKE FOREST, Ill. — Generic drug maker Hospira will have its investor conference next week, the company said Tuesday.

The drug maker, based in the Chicago area, will have the investor day at its headquarters on Dec. 5. Hospira specializes in manufacturing injectable generic drugs, including biosimilars for the European market.

The event will include slide presentations, and the company will stream it via audio webcast at its investors website, hospirainvestor.com.

 

November 26, 2013

The Food and Drug Administration has approved a new tablet form of an antifungal drug made by Merck, the company said Tuesday.

WHITEHOUSE STATION, N.J. — The Food and Drug Administration has approved a new tablet form of an antifungal drug made by Merck, the company said Tuesday.

Merck announced the FDA approval of Noxafil (posaconazole) 100-mg delayed release tablets. The company also markets a 40-mg-per-milliliter oral suspension form of the drug. The new tablet formulation is designed to be taken in two 300-mg doses on the first day, followed by a 300-mg dose once per day.

November 26, 2013

QRxPharma has resubmitted its regulatory approval application for an opioid painkiller for which it has sought Food and Drug Administration approval since 2011, the company said Tuesday.

BEDMINSTER, N.J. — QRxPharma has resubmitted its regulatory approval application for an opioid painkiller for which it has sought Food and Drug Administration approval since 2011, the company said Tuesday.

The Australian drug maker announced the resubmission of its application for Moxduo, a pill that combines oxycodone and morphine.The FDA is expected to schedule an advisory committee meeting to review the application for May 2014.

November 26, 2013

The number of patients receiving prescriptions for statins is expected to increase modestly following new cholesterol recommendations from the American College of Cardiology and the American Heart Association, according to a new report.

SAN MATEO, Calif. – The number of patients receiving prescriptions for statins is expected to increase modestly following new cholesterol recommendations from the American College of Cardiology and the American Heart Association, according to a new report.